Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network

Global and national high blood pressure burden and control

(2021) Tu N Nguyen et al.   LANCET

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

(2021) Bin Zhou et al.   LANCET

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

(2021) Bin Zhou et al.   Nature Reviews Cardiology

Will the zero-margin drug policy reduce the economic burden of stroke patients in China?

(2021) Quan Fang et al.   Journal of Global Health

The global epidemiology of hypertension

(2020) Katherine T. Mills et al.   Nature Reviews Nephrology

Future of Hypertension

(2019) Victor J. Dzau et al.   HYPERTENSION

Differences in the treatment and control of hypertension in urban and rural residents of the northeastern region of the People’s Republic of China: a cross-sectional study

(2018) Lei Zhao et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Gender Differences in Epidemiology, Pathophysiology, and Treatment of Hypertension

(2018) Paolo Di Giosia et al.   Current Atherosclerosis Reports

Geographical variations in hypertension prevalence, awareness, treatment and control in China

(2018) Yichong Li et al.   JOURNAL OF HYPERTENSION

Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003–2014

(2018) Elizabeth B. Kirkland et al.   Journal of the American Heart Association

Prevalence, Awareness, Treatment, Control and Risk Factors Associated with Hypertension among Adults in Southern China, 2013

(2016) Li Yang et al.   PLoS One

Prevalence, Awareness, Treatment, and Control of Hypertension in China: Results From a National Survey

(2014) J. Wang et al.   AMERICAN JOURNAL OF HYPERTENSION

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Discordance in National Estimates of Hypertension Among Young Adults

(2011) Quynh C. Nguyen et al.   EPIDEMIOLOGY

The cardiovascular continuum refined: A hypothesis

(2010) Massimo Volpe et al.   BLOOD PRESSURE

Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina

(2008) M. C. Christensen et al.   ACTA NEUROLOGICA SCANDINAVICA

Pharmaceutical Policy In China

(2008) Qiang Sun et al.   HEALTH AFFAIRS